about
Monitoring of anti-cancer treatment with (18)F-FDG and (18)F-FLT PET: a comprehensive review of pre-clinical studiesImaging Cellular Proliferation in Prostate Cancer with Positron Emission TomographyEvaluation of FLT-PET-CT as an imaging biomarker of proliferation in primary breast cancer.Potentiation of tumor responses to DNA damaging therapy by the selective ATR inhibitor VX-970Positron Emission Tomography (PET) in Oncology18F-FDG and 18F-FLT-PET imaging for monitoring everolimus effect on tumor-growth in neuroendocrine tumors: studies in human tumor xenografts in miceFDG and FLT-PET for Early measurement of response to 37.5 mg daily sunitinib therapy in metastatic renal cell carcinoma.18F-FLT PET/CT in the Evaluation of Pheochromocytomas and Paragangliomas: A Pilot Study.18F-fluorothymidine PET imaging in gliomas: an update.Quantitative multimodality imaging in cancer research and therapyIn vivo imaging of cellular proliferation in renal cell carcinoma using 18F-fluorothymidine PETThe relationship between endogenous thymidine concentrations and [(18)F]FLT uptake in a range of preclinical tumour models.Effects of capecitabine treatment on the uptake of thymidine analogs using exploratory PET imaging agents: 18F-FAU, 18F-FMAU, and 18F-FLT.PET of Glucose Metabolism and Cellular Proliferation in Prostate Cancer.Evaluation of 18F-fluorothymidine positron emission tomography ([18F]FLT-PET/CT) methodology in assessing early response to chemotherapy in patients with gastro-oesophageal cancer.FLT PET-CT in evaluation of treatment response.PET in the management of locally advanced and metastatic NSCLC.Emerging clinical applications of PET based molecular imaging in oncology: the promising future potential for evolving personalized cancer care.Failed PET Application Attempts in the Past, Can We Avoid Them in the Future?The preliminary study of 18F-FLT micro-PET/CT in predicting radiosensitivity of human nasopharyngeal carcinoma xenografts.Targeted Prostate Gland Biopsy With Combined Transrectal Ultrasound, mpMRI, and 18F-FMAU PET/CT.3'-Deoxy-3'-¹⁸F-fluorothymidine positron emission tomography as an early predictor of disease progression in patients with advanced and metastatic pancreatic cancer.Sex as a Biological Variable in Preclinical Imaging Research: Initial Observations with 18F-Fluorothymidine.Correlation of Glioma Proliferation and Hypoxia by Luciferase, Magnetic Resonance, and Positron Emission Tomography Imaging.ORGAN DOSES AND EFFECTIVE DOSE FOR FIVE PET RADIOPHARMACEUTICALS.Utilizing radiolabeled 3'-deoxy-3'-[18F]fluorothymidine with positron emission tomography to monitor the effect of dexamethasone on non-small cell lung cancer.(18)F-FDG and (18)F-FLT PET/CT imaging in the characterization of mediastinal lymph nodes.Imaging of molecular target modulation in oncology: challenges of early clinical trials
P2860
Q26778463-49450F8F-10E1-43B7-9C71-B4A8FCD59083Q28066696-9356DC0F-9804-4735-BFBF-A7284E1D34ECQ33750115-47FA7B05-130C-48CE-9DA6-A647F5C3EFE0Q34221860-D15C1406-DFB8-4D1A-AEC3-7F0CBBB46C0BQ34774840-980F0B89-717B-47C0-B28B-8380CF9D1595Q35120054-DC0F7C75-24E8-4B31-B2B3-C4AF7E13A867Q36023626-EEDD3E46-F247-461C-86F6-D6BC1B621A9EQ36342833-B9416F1B-1496-400E-B814-FEEB24FD7679Q36404866-E4BA47AC-F76E-40F2-983B-172882A5F43FQ37007810-4ECC5BCA-5778-4318-AA39-A9C55634ECB0Q37077354-D69650D7-5099-4EF4-B40F-37331C12D3B4Q37167105-3B92891D-214B-4E65-BCAD-04FACDE2C86EQ37346140-097DEA03-243D-4486-9AED-64B2DCD39A94Q37390670-15375DF4-F523-4CF5-93A6-454AFC213C10Q37418581-0CBA85B9-72E0-4021-AE46-80B85EA73D26Q38206772-698650F3-0D2F-400E-97F6-1D2A18CC804EQ38444980-E41D09D8-6C7B-419A-959C-AE35AE118701Q38692408-2278D34A-C4D7-446E-8627-0289039E5C8EQ38800009-A1870EE5-32BE-4CD9-846D-5A884FF8ACC2Q38957000-F99184F2-8992-48F9-A10D-07F2C705E7B4Q41263920-4B8BC7AE-849C-41E0-9849-89981C23ADD4Q41448654-579C6C1C-684B-4CCB-A5BC-DCCA56E67FDDQ47567896-9666C5AB-5535-4A64-8972-3FA089CD59E0Q47866324-CDAEA4AD-AA2C-4A9F-9B34-D9835C80C578Q51443992-1592CDA0-D957-4871-9038-4CF77CD1AAE2Q52718193-9BB2FA78-8DE0-4CAD-B772-D893A7152E15Q52986927-51095C5F-AC03-4958-9456-2A443E5CDE5CQ57758791-D3CCDEC8-2F65-4842-B10C-42369670DB87
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
PET imaging of proliferation with pyrimidines
@ast
PET imaging of proliferation with pyrimidines
@en
PET imaging of proliferation with pyrimidines
@nl
type
label
PET imaging of proliferation with pyrimidines
@ast
PET imaging of proliferation with pyrimidines
@en
PET imaging of proliferation with pyrimidines
@nl
prefLabel
PET imaging of proliferation with pyrimidines
@ast
PET imaging of proliferation with pyrimidines
@en
PET imaging of proliferation with pyrimidines
@nl
P3181
P1476
PET imaging of proliferation with pyrimidines
@en
P2093
A. F. Shields
O. S. Tehrani
P304
P3181
P356
10.2967/JNUMED.112.112201
P407
P577
2013-06-01T00:00:00Z